NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Window openFRAMEWORKSME SUITABLEScore 76/100
- Buyer
- NHS England
- Current holder
- Upgrade to see
- Contract value
- £35,312,548
- Contract ends
- 31 Aug 2027 (343 days)
- Re-tender likely opens
- Upgrade to see
- Category
- goods
- CPV codes
- 33600000
Why it scores 76
- Value31
- Timing29
- Unclaimed0
- Recurrence12
- Access4
A later notice from this buyer in the same CPV family suggests this may already have been re-tendered.
How contested is this?
Buyers publish how many bids they received. Across 46 comparable procurements we can tell you the typical field size, how often one of these goes uncontested, and whether the buyer awards on price or on quality.
Notice history
6 events · 6 releases on Find a Tender
- Pipeline or early engagement notice13 Jan 2026, 09:57 GMT002508-2026
- Notice published13 Mar 2026, 15:08 GMT023102-2026
- Tender notice17 Mar 2026, 12:14 GMT023990-2026
- Award decision published23 Jun 2026, 12:33 BST058925-2026
- Award updated9 Jul 2026, 15:45 BST064847-2026
- Award decision published21 Jul 2026, 11:16 BST068603-2026